A detailed history of Cromwell Holdings LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cromwell Holdings LLC holds 180 shares of CRL stock, worth $31,490. This represents 0.02% of its overall portfolio holdings.

Number of Shares
180
Previous 28 542.86%
Holding current value
$31,490
Previous $4,000 575.0%
% of portfolio
0.02%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$99.75 - $151.89 $15,162 - $23,087
152 Added 542.86%
180 $27,000
Q1 2025

Apr 30, 2025

SELL
$150.52 - $190.14 $5,870 - $7,415
-39 Reduced 58.21%
28 $4,000
Q4 2024

Feb 03, 2025

SELL
$178.58 - $220.69 $14,286 - $17,655
-80 Reduced 54.42%
67 $12,000
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $30,339 - $39,503
147 New
147 $30,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.